GlassScriptPhysician profile
Luke Alan Johnson
NPI 1457702623
$1,081.96
in general payments reported to CMS, 2019-2025
16 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $156 · 2021: $125 · 2023: $76.71 · 2024: $290 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $281.01 | 2020-2021 | |
| Novo Nordisk INC | $152.73 | 2019-2024 | Wegovy, Rybelsus, Ozempic |
| Abbott Laboratories | $108.80 | 2024 | Proclaim |
| Stryker Corporation | $108.75 | 2024 | Gamma |
| Lilly USA, LLC | $90.74 | 2019 | |
| Inspire Medical Systems, INC. | $74.98 | 2025 | Inspire |
| Abbvie INC. | $52.39 | 2023-2024 | |
| Tactile Systems Technology INC | $36.80 | 2025 | Flexitouch Plus, Nimbl |
| Abiomed | $30.57 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.03 | 2023 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $24.24 | 2025 | Takhzyro |
| Hologic Sales and Service, LLC | $24.22 | 2025 | Thinprep 2000 Processor |
| Janssen Biotech, INC. | $21.57 | 2024 | Stelara |
| Xeris Pharmaceuticals, INC. | $17.32 | 2025 | Gvoke Hypopen |
| Exact Sciences Corporation | $17.10 | 2025 | Cologuard Collection Kit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.